Maxigen Biotech Inc. (TPE:1783)
Taiwan
· Delayed Price · Currency is TWD 42.45
+0.95 (2.29%)
Mar 10, 2026, 9:31 AM CST
Maxigen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,349 | 4,365 | 4,304 | 4,036 | 3,996 | 1,591 | Upgrade
|
| Market Cap Growth | -25.63% | 1.40% | 6.65% | 0.99% | 151.22% | -9.31% | Upgrade
|
| Enterprise Value | 2,618 | 3,821 | 3,884 | 3,324 | 3,534 | 1,454 | Upgrade
|
| Last Close Price | 41.50 | 48.03 | 46.47 | 43.20 | 42.77 | 18.66 | Upgrade
|
| PE Ratio | 16.02 | 22.95 | 25.96 | 28.95 | 45.59 | 25.13 | Upgrade
|
| Forward PE | - | 10.53 | 10.53 | 10.53 | 10.53 | 10.53 | Upgrade
|
| PS Ratio | 4.23 | 6.41 | 6.92 | 6.68 | 7.81 | 3.48 | Upgrade
|
| PB Ratio | 2.27 | 3.17 | 3.16 | 3.12 | 3.50 | 1.85 | Upgrade
|
| P/TBV Ratio | 2.27 | 3.17 | 3.16 | 3.12 | 3.51 | 1.85 | Upgrade
|
| P/FCF Ratio | 14.98 | 16.38 | 28.94 | 15.89 | 38.67 | 24.92 | Upgrade
|
| P/OCF Ratio | 12.09 | 14.64 | 25.14 | 15.04 | 33.98 | 21.33 | Upgrade
|
| EV/Sales Ratio | 3.30 | 5.61 | 6.24 | 5.50 | 6.90 | 3.18 | Upgrade
|
| EV/EBITDA Ratio | 9.75 | 18.48 | 21.94 | 21.21 | 29.51 | 15.95 | Upgrade
|
| EV/EBIT Ratio | 10.96 | 21.24 | 25.92 | 25.84 | 39.28 | 23.80 | Upgrade
|
| EV/FCF Ratio | 11.71 | 14.34 | 26.11 | 13.08 | 34.20 | 22.79 | Upgrade
|
| Debt / Equity Ratio | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.08 | 0.13 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.09 | 0.19 | Upgrade
|
| Net Debt / Equity Ratio | -0.50 | -0.46 | -0.32 | -0.62 | -0.45 | -0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.72 | -3.09 | -2.43 | -5.10 | -4.32 | -2.17 | Upgrade
|
| Net Debt / FCF Ratio | -3.27 | -2.40 | -2.90 | -3.15 | -5.01 | -3.10 | Upgrade
|
| Asset Turnover | 0.49 | 0.44 | 0.42 | 0.45 | 0.46 | 0.43 | Upgrade
|
| Inventory Turnover | 3.10 | 2.45 | 2.46 | 2.95 | 2.98 | 2.76 | Upgrade
|
| Quick Ratio | 3.77 | 3.61 | 4.02 | 5.94 | 5.53 | 3.60 | Upgrade
|
| Current Ratio | 4.19 | 4.03 | 4.72 | 6.56 | 6.75 | 4.99 | Upgrade
|
| Return on Equity (ROE) | 16.67% | 13.90% | 12.48% | 11.44% | 8.76% | 7.40% | Upgrade
|
| Return on Assets (ROA) | 9.21% | 7.31% | 6.37% | 5.93% | 5.06% | 3.57% | Upgrade
|
| Return on Invested Capital (ROIC) | 29.04% | 18.21% | 18.05% | 19.31% | 12.57% | 7.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.10% | 13.10% | 11.00% | 9.90% | 7.80% | 7.00% | Upgrade
|
| Earnings Yield | 6.99% | 4.36% | 3.85% | 3.45% | 2.19% | 3.98% | Upgrade
|
| FCF Yield | 6.68% | 6.11% | 3.46% | 6.30% | 2.59% | 4.01% | Upgrade
|
| Dividend Yield | 1.93% | 1.73% | 2.15% | 1.10% | - | 3.39% | Upgrade
|
| Payout Ratio | 31.80% | 46.78% | 25.54% | - | 64.18% | 85.58% | Upgrade
|
| Buyback Yield / Dilution | -0.62% | -0.27% | -0.07% | -5.78% | -4.81% | 8.21% | Upgrade
|
| Total Shareholder Return | 1.31% | 1.46% | 2.08% | -4.68% | -4.81% | 11.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.